Literature DB >> 24977116

High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.

Michael S Kostapanos1, Moses S Elisaf1.   

Abstract

Patients with type 2 diabetes mellitus (T2DM) frequently exhibit macrovascular complications of atherosclerotic cardiovascular (CV) disease. High density lipoproteins (HDL) are protective against atherosclerosis. Low levels of HDL cholesterol (HDL-C) independently contribute to CV risk. Patients with T2DM not only exhibit low HDL-C, but also dysfunctional HDL. Furthermore, low concentration of HDL may increase the risk for the development of T2DM through a decreased β cell survival and secretory function. In this paper, we discuss emerging concepts in the relationship of T2DM with HDL.

Entities:  

Keywords:  High density lipoproteins; Insulin secretion; Paraoxonase-1; Type 2 diabetes; β cells

Year:  2014        PMID: 24977116      PMCID: PMC4073260          DOI: 10.5493/wjem.v4.i1.1

Source DB:  PubMed          Journal:  World J Exp Med        ISSN: 2220-315X


  72 in total

Review 1.  Multiple actions of high-density lipoprotein.

Authors:  Matilda Florentin; Evangelos N Liberopoulos; Anthony S Wierzbicki; Dimitri P Mikhailidis
Journal:  Curr Opin Cardiol       Date:  2008-07       Impact factor: 2.161

2.  Biomechanical evaluation of knotless anatomical double-layer double-row rotator cuff repair: a comparative ex vivo study.

Authors:  Pierre Hepp; Georg Osterhoff; Thomas Engel; Bastian Marquass; Thomas Klink; Christoph Josten
Journal:  Am J Sports Med       Date:  2009-03-23       Impact factor: 6.202

3.  Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age.

Authors:  M Cnop; A Grupping; A Hoorens; L Bouwens; M Pipeleers-Marichal; D Pipeleers
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction.

Authors:  Richard W Grant; James B Meigs
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

Review 5.  Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.

Authors:  M A Austin
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

6.  Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability.

Authors:  D L Sparks; W S Davidson; S Lund-Katz; M C Phillips
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

7.  Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties.

Authors:  Orit Rozenberg; Maayan Shiner; Michael Aviram; Tony Hayek
Journal:  Free Radic Biol Med       Date:  2008-03-08       Impact factor: 7.376

8.  U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

Review 9.  Free fatty acids and skeletal muscle insulin resistance.

Authors:  Edward W Kraegen; Gregory J Cooney
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

10.  Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

Authors:  Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461

View more
  4 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  Serum paraoxonase 1 activity in patients with iron deficiency anemia.

Authors:  Yildiz Okuturlar; Asuman Gedikbasi; Nilgul Akalin; Meral Gunaldi; Deniz Yilmaz; Meral Mert; Ozlem Harmankaya; Aliye Soylu; Pinar Karakaya; Abdulbaki Kumbasar
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

3.  Dietary Iron Restriction Improves Muscle Function, Dyslipidemia, and Decreased Muscle Oxidative Stress in Streptozotocin-Induced Diabetic Rats.

Authors:  Manuel Alejandro Vargas-Vargas; Alfredo Saavedra-Molina; Mariana Gómez-Barroso; Donovan Peña-Montes; Christian Cortés-Rojo; Huerta Miguel; Xochitl Trujillo; Rocío Montoya-Pérez
Journal:  Antioxidants (Basel)       Date:  2022-04-07

4.  Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet Hamsters.

Authors:  Chia-Chun Wu; Yu-Hsuan Cheng; Kuo-Hsin Chen; Chiang-Ting Chien
Journal:  Life (Basel)       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.